Integrated Filing — IndAS



General information about company

Scrip Code 000000
NSE Symbol BALAJIPHOS
MSEI Symbol NOTLISTED
ISIN INE0PQ601019
Name of company BALAJI PHOSPHATES LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 29-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 29-05-2026   15:00:00
End date and time of board meeting 29-05-2026   19:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 8,576.66 17,047.38
Other income 11.40 72.36
Total income 8,588.06 17,119.74
2 Expenses
(a) Cost of materials consumed 6,290.15 12,083.08
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 23.47 (754.67)
(d) Employee benefit expense 512.07 990.56
(e) Finance costs 176.25 358.99
(f) Depreciation, depletion and amortisation expense 63.42 114.47
(f) Other Expenses
1 Other Expenses 1,114.81 2,829.31
Total other expenses 1,114.81 2,829.31
Total expenses 8,180.17 15,621.74
3 Total profit before exceptional items and tax 407.89 1,498.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 407.89 1,498.00
6 Tax expense
7 Current tax 193.97 475.18
8 Deferred tax (3.66) 0.41
9 Total tax expenses 190.31 475.59
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 217.58 1,022.41
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 217.58 1,022.41
17 Other comprehensive income net of taxes (0.75) (0.75)
18 Total Comprehensive Income for the period 216.83 1,021.66
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 216.57 1,022.39
Total profit or loss, attributable to non-controlling interests 0.01 0.02
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 216.82 1,021.64
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.01 0.02
21 Details of equity share capital
Paid-up equity share capital 2,377.71 2,377.71
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 9,065.64
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.91 4.3
Diluted earnings (loss) per share from continuing operations 0.91 4.3
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.91 4.3
Diluted earnings (loss) per share from continuing and discontinued operations 0.91 4.3
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 700.82
Capital work-in-progress 1,183.42
Investment property
Goodwill 539.18
Other intangible assets 0.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other Financial Assets 100.00
Total of other non-current financial assets 100.00
Total non-current financial assets 100.00
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 219.16
Total of other non-current assets 219.16
Total non-current assets 2,742.58
2 Current assets
Inventories 5,783.53
Current financial asset
Current investments 0.00
Trade receivables, current 6,787.69
Cash and cash equivalents 22.05
Bank balance other than cash and cash equivalents 148.64
Loans, current 0.00
Other current financial assets
Total of other current financial assets 159.11
Total current financial assets 7,117.49
Current tax assets (net)
Other current assets
1 Other current assets 651.15
Total of other current assets 651.15
Total current assets 13,552.17
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 16,294.75
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 2,377.71
Other equity 6,687.93
Total equity attributable to owners of parent 9,065.64
Non controlling interest 0.09
Total equity 9,065.73
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 944.17
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other Financial Liabilities 0.00
Total of other non-current financial liabilities 0.00
Total non-current financial liabilities 944.17
Provisions, non-current 6.57
Deferred tax liabilities (net) 4.22
Deferred government grants, Non-current
Other non-current liabilities
1 Other non-current liabilities 0.00
Total of other non-current liabilities 0.00
Total non-current liabilities 954.96
Current liabilities
Current financial liabilities
Borrowings, current 3,303.47
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 1,062.06
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 864.46
Total Trade payable 1,926.52
Other current financial liabilities
1 Other current financial liabilities 119.30
Total of other current financial liabilities 119.30
Total current financial liabilities 5,349.29
Other current liabilities 505.61
1 Other current liabilities 505.61
Total of other current liabilities 505.61
Provisions, current 2.42
Current tax liabilities (Net) 416.74
Deferred government grants, Current
Total current liabilities 6,274.06
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 7,229.02
Total equity and liabilites 16,294.75
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Fertilisers 6,529.78 13,547.64
2 Weighing Bridge, Spare parts & Maintanance 2,046.88 3,499.74
Total Segment Revenue 8,576.66 17,047.38
Less: Inter segment revenue
Revenue from operations 8,576.66 17,047.38
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Fertilisers 434.93 1,682.26
2 Weighing Bridge, Spare parts & Maintanance 149.21 174.74
Total Profit before tax 584.14 1,857.00
i. Finance cost 176.25 358.99
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax 407.89 1,498.01
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Fertilisers 13,922.50 13,922.50
2 Weighing Bridge, Spare parts & Maintanance 1,833.07 1,833.07
Total Segment Asset 15,755.57 15,755.57
Un-allocable Assets 539.18 539.18
Net Segment Asset 16,294.75 16,294.75
4 Segment Liabilities
Segment Liabilities
1 Fertilisers 6,021.57 6,021.57
2 Weighing Bridge, Spare parts & Maintanance 1,207.45 1,207.45
Total Segment Liabilities 7,229.02 7,229.02
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 7,229.02 7,229.02
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Gain/(Loss) on remeasurement of defined benefit plans (1.00) (1.00)
2 Income tax related to items that will not be reclassified to Profit and loss 0.25 0.25
Total Amount of items that will not be reclassified to profit and loss (0.75) (0.75)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (0.75) (0.75)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1,498.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0.00
Adjustments for decrease (increase) in inventories (1,808.42)
Adjustments for decrease (increase) in trade receivables, current (2,342.09)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (86.39)
Adjustments for decrease (increase) in other non-current assets 806.14
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 747.81
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 1,206.56
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 79.47
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 114.47
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 1.67
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 14.84
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) (0.35)
Other adjustments for non-cash items 23.42
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (1,242.87)
Net cash flows from (used in) operations 255.13
Dividends received 0.00
Interest paid (358.99)
Interest received (41.81)
Income taxes paid (refund) 101.17
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 471.14
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.46
Purchase of property, plant and equipment 1,233.86
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 41.81
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (104.31)
Net cash flows from (used in) investing activities (1,295.90)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 1,120.40
Repayments of borrowings 0.00
Payments of lease liabilities 0.00
Dividends paid 0.00
Interest paid 358.99
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 40.00
Net cash flows from (used in) financing activities 801.41
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (23.35)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (23.35)
Cash and cash equivalents cash flow statement at beginning of period 45.40
Cash and cash equivalents cash flow statement at end of period 22.05